Updated throughout and filled with all the latest research, treatment plans, commonly asked questions and more, the bestselling resource on schizophrenia is back—now in its seventh edition. “E. Fuller Torrey is a brilliant writer. There is no one writing on psychology today whom I would rather read.”— Los Angeles Times Since its first publication in 1983, […]
This book is the only clinical guide exclusively on the treatment of medical comorbidities among patients with schizophrenia. Like its best-selling predecessor, this new, expanded edition compiles the latest research and clinical information regarding the crucial task of integrating medical and psychiatric care for the schizophrenic patient.
In an article in this issue Heald et al (1) in their study on characterization of depression in schizophrenia report that the precise nature of depressive symptoms present in different phases of the schizophrenic illness can be differentiated qualitatively from primary depression. The authors introduce about the history, prevalence and importance of depressive symptoms in […]
In recent years, health-related quality of life (QOL) has been regarded as the most important dimension of outcome in schizophrenia and other serious mental disorders (1). However, the determinants of quality of life are poorly understood in this population. Studies have relied on combined measures of subjective and objective QOL (2). Indicators of QOL include […]
Byline: Wahid Bakhsh Sajid, Shahid Rashid and Farrukh Akhtar Abstract